Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page removes the generic government funding/operating-status notice.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedVersion history shows multiple updates to core trial details (recruitment status, study status, and site/ contact information) across several versions. These changes reflect updates to current trial progress and site information.SummaryDifference0.0%

- Check47 days agoChange DetectedCore content updated with a government funding notice and a new version number (v3.2.0) replacing the old one (v3.1.0); reflects status and version changes rather than substantive feature additions.SummaryDifference7%

- Check54 days agoChange DetectedMajor version update to v3.1.0 with a new study status entry and date; older revision v3.0.2 and its date removed.SummaryDifference0.9%

- Check68 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release, and the 'Back to Top' element was removed; overall, core content remains unchanged.SummaryDifference0.4%

- Check76 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.